search
Back to results

Novel Stretching Device Versus Night Splints

Primary Purpose

Plantar Fasciitis

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Night splints
Triceps Surae Stretching and Flexibility Assessment Device (TESS)
Sponsored by
SAE Orthopedics
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Plantar Fasciitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age 18 years and older
  • diagnosis of plantar fasciitis
  • ability to understand the purpose of the study
  • ability to safely use the device they are assigned after education and return demonstration.

Exclusion Criteria:

  • patients with ankle fusion or significant balance impairment which would prohibit safe use of the TESS device

Sites / Locations

  • SAE Orthopedics

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Main study

Arm Description

This is the only arm of the study. It is a 6 week period where the participants will either be using night splints or the TESS device to treat their plantar fasciitis symptoms.

Outcomes

Primary Outcome Measures

Number of participants who will attend follow up appointment and describe their symptoms and pain using a standard 0-10 pain chart.
The participant will return their device and fill out a questionnaire (the same as the original questionnaire from the first visit) that will ask them to describe their symptoms and pain levels using a standard 0-10 pain scale chart. The investigators will then use a Mixed ANCOVA statistical test to compare the effectiveness of the TESS device to night splints in symptom relief.

Secondary Outcome Measures

Full Information

First Posted
January 3, 2022
Last Updated
May 25, 2022
Sponsor
SAE Orthopedics
search

1. Study Identification

Unique Protocol Identification Number
NCT05216679
Brief Title
Novel Stretching Device Versus Night Splints
Official Title
Novel Stretching Device Versus Night Splints a Prospective, Randomized Study in the Effectiveness of Treating Plantar Fasciitis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
June 14, 2022 (Anticipated)
Primary Completion Date
September 1, 2022 (Anticipated)
Study Completion Date
December 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
SAE Orthopedics

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
A set of 100 patients previously diagnosed with plantar fasciitis will be given initial questionnaires about their symptoms and randomly assigned either night splints or the novel calf stretching device. The participants will use each device for 6 weeks. At the end of those 6 weeks, they will return for a follow up questionnaire. The answers in the questionnaire will be analyzed to compare the effectiveness of night splints to calf stretching.
Detailed Description
The attached recruitment brochure will be distributed to physician's offices, and possibly placed as an ad in the newspaper. Potential participants will call the enclosed number and an appointment will be arranged to be evaluated at our research facility in Carterville, IL. During their initial evaluation which will take 30 minutes to 1 hour, each participant will complete medical history pertinent to plantar fasciitis and questionnaires regarding symptoms and physical activity. The research participants will then stand on the tssfad1 device for 5 to 10 minutes during which time their triceps surae flexibility will be assessed by measuring the distance from their heel to the platform at the 30-degree setting. Measurements for each foot will be taken with a distance sensor every 5 seconds for a 5 minute period. The investigators will then use a random number generator program from www.random.org to generate a number between 1 and 100. Participants with an odd number will be assigned home use of standard night splints. Those with an even number will be provided with a TESS unit to be used at home a minimum of 5 minutes twice per day. The participants will use their device for 6 weeks. They will receive a check in phone call at the 3 week mark of their participation. Contact numbers will be given to each participant should they have any questions or concerns during the six-week interval. Each participant will be asked to maintain a daily log of their pain level on a visual analog scale and of their estimated time using each device. Participant's random number will be used to link data in the study to the participant. The investigators will not be using patient identifiable information such as name, date of birth, medical record number, or other personal information for the record.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Plantar Fasciitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Main study
Arm Type
Experimental
Arm Description
This is the only arm of the study. It is a 6 week period where the participants will either be using night splints or the TESS device to treat their plantar fasciitis symptoms.
Intervention Type
Device
Intervention Name(s)
Night splints
Intervention Description
A night splint is a brace the patient wears on their foot to keep it in a dorsiflexed position while they sleep. It is the first line treatment for plantar fasciitis.
Intervention Type
Device
Intervention Name(s)
Triceps Surae Stretching and Flexibility Assessment Device (TESS)
Intervention Description
The TESS device is a slant board with a bar added for balance that the participant will stand on in 5 minute intervals throughout the day to stretch their calves, and potentially treat their plantar fasciitis symptoms.
Primary Outcome Measure Information:
Title
Number of participants who will attend follow up appointment and describe their symptoms and pain using a standard 0-10 pain chart.
Description
The participant will return their device and fill out a questionnaire (the same as the original questionnaire from the first visit) that will ask them to describe their symptoms and pain levels using a standard 0-10 pain scale chart. The investigators will then use a Mixed ANCOVA statistical test to compare the effectiveness of the TESS device to night splints in symptom relief.
Time Frame
6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 18 years and older diagnosis of plantar fasciitis ability to understand the purpose of the study ability to safely use the device they are assigned after education and return demonstration. Exclusion Criteria: patients with ankle fusion or significant balance impairment which would prohibit safe use of the TESS device
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mike Davis, MD
Phone
618-525-3505
Email
mdavis1060@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Emma Hughes, BS
Phone
217-414-5323
Email
ekhughes98@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mike Davis', MD
Organizational Affiliation
SAE Orthopedics
Official's Role
Principal Investigator
Facility Information:
Facility Name
SAE Orthopedics
City
Carterville
State/Province
Illinois
ZIP/Postal Code
62918
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mike Davis, MD
Phone
618-525-3505
Email
mdavis1060@gmail.com
First Name & Middle Initial & Last Name & Degree
Emma Hughes, BS
First Name & Middle Initial & Last Name & Degree
Ashley-Anne Walker, BS
First Name & Middle Initial & Last Name & Degree
Amanda Jacobson

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All data that underlie a publication will be shared.
IPD Sharing Time Frame
Data will become available 6 months after study publication. Data will remain available indefinitely.
IPD Sharing Access Criteria
Dr. Davis will review requests to access study data on a case by case basis. All deidentified data from this study has potential to be shared with other researchers. Requests can be made via email to james.m.davis1@siu.edu.

Learn more about this trial

Novel Stretching Device Versus Night Splints

We'll reach out to this number within 24 hrs